- Works count
- 812
- Citation count
- 21,459
- H-index
- 69
- i10-index
- 344
Research interests
Publications
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer
Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.02914
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer
Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.01124
Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer
Annals of Surgery · 2018 · https://doi.org/10.1097/sla.0000000000002803
Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis
The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30108-6
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(15)00553-7
Multicenter Prospective Comparative Study of Robotic Versus Laparoscopic Gastrectomy for Gastric Adenocarcinoma
Annals of Surgery · 2015 · https://doi.org/10.1097/sla.0000000000001249
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(11)61873-4
Current projects
No projects listed.